Axillary reverse mapping in breast cancer: Can we spare what we find? [8]

Annals of Surgical Oncology

Volumn 15, Issue 1, 2008, Pages 390-391

  Ponzone, Riccardo ^a   Mininanni, Paola ^a   Cassina, Elisa ^a   Sismondi, Piero ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURGERY; HUMAN; LETTER; LYMPH FLOW; LYMPHATIC DRAINAGE; LYMPHEDEMA; METASTASIS; PILOT STUDY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; PILOT PROJECTS; PROGNOSIS; ROSANILINE DYES;

EID: 38049151238     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9663-6     Document Type: Letter

References (4)

1. Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 2007;14:1890-1895
2. Nos C, Lesieur B, Clough KB, Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol. E-pub ahead of print, 2007
3. Sakorafasa GH, Perosa G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006;15:153-165
4. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Cancer Inst 2006;98:599-609